The high abundance and cytokine production capacity5, along with the presence of shared TCR features in synovial cit-TNC specific CD4 + T cells from patients with ACPA positive RA suggests an active role for cit-TNC specific immune responses in clinical manifestations and joint damage in this RA subset. The gene discussed is PRTN3; the disease is rheumatoid arthritis.